Jennison Associates’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $850M | Buy |
|
|||||
|
2025
Q1 | $776M | Sell |
|
|||||
|
2024
Q4 | $1.01B | Buy |
|
|||||
|
2024
Q3 | $1.17B | Sell |
|
|||||
|
2024
Q2 | $1.33B | Sell |
|
|||||
|
2024
Q1 | $1.17B | Sell |
|
|||||
|
2023
Q4 | $1.19B | Sell |
|
|||||
|
2023
Q3 | $1.55B | Buy |
|
|||||
|
2023
Q2 | $1.56B | Buy |
|
|||||
|
2023
Q1 | $1.12B | Buy |
|
|||||
|
2022
Q4 | $359M | Buy |
|
|||||
|
2022
Q3 | $244M | Buy |
|
|||||
|
2022
Q2 | $272M | Buy |
|
|||||
|
2022
Q1 | $243M | Buy |
|
|||||
|
2021
Q4 | $164M | Sell |
|
|||||
|
2021
Q3 | $183M | Sell |
|
|||||
|
2021
Q2 | $183M | Buy |
|
|||||
|
2021
Q1 | $146M | Sell |
|
|||||
|
2020
Q4 | $496M | Sell |
|
|||||
|
2020
Q3 | $1.7B | Sell |
|
|||||
|
2020
Q2 | $2.07B | Buy |
|
|||||
|
2020
Q1 | $1.73B | Buy |
|
|||||
|
2019
Q4 | $1.83B | Buy |
|
|||||
|
2019
Q3 | $1.6B | Buy |
|
|||||
|
2019
Q2 | $1.4B | Sell |
|
|||||
|
2019
Q1 | $1.76B | Sell |
|
|||||
|
2018
Q4 | $1.74B | Buy |
|
|||||
|
2018
Q3 | $1.57B | Buy |
|
|||||
|
2018
Q2 | $677M | Buy |
|
|||||
|
2017
Q3 | – | Sell |
|
|||||
|
2017
Q2 | $67.6M | Buy |
|
|||||
|
2017
Q1 | $61.4M | Sell |
|
|||||
|
2016
Q4 | $62.5M | Buy |
|
|||||
|
2016
Q3 | $27.9M | Sell |
|
|||||
|
2016
Q2 | $25.8M | Sell |
|
|||||
|
2016
Q1 | $85.5M | Buy |
|
|||||
|
2015
Q4 | $102M | Sell |
|
|||||
|
2015
Q3 | $124M | Buy |
|
|||||
|
2015
Q2 | $85.5M | Buy |
|
|||||
|
2015
Q1 | $91.1M | Buy |
|
|||||
|
2014
Q4 | $67M | Buy |
|
|||||
|
2014
Q2 | – | Sell |
|
|||||
|
2014
Q1 | $73.5M | Buy |
|